glutamic acid has been researched along with cyclo(prolylglycyl) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antipova, TA; Gudasheva, TA; Kolyasnikova, KN; Nikolaev, SV; Povarnina, PY | 1 |
| Antipova, TA; Gudasheva, TA; Koliasnikova, KN; Seredenin, SB | 1 |
2 other study(ies) available for glutamic acid and cyclo(prolylglycyl)
| Article | Year |
|---|---|
Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity.
Topics: Animals; Brain Ischemia; Cell Line; Glutamic Acid; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Peptides, Cyclic; Rats | 2016 |
Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutamic Acid; Hippocampus; Humans; Mice; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Peptides, Cyclic; Piracetam | 2016 |